Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VinCaP phase II trial of vinflunine in advanced penile cancer
2012-002592-34Phase 2Completed
- Sponsor
- The Institute of Cancer Research
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vinflunine in penile squamous cell carcinoma (PSCC), sponsored by The Institute of Cancer Research. Primary endpoint: Clinical benefit rate. Started Jul 2013; status: completed.
02
Drugs
vinflunine
03
Conditions
penile squamous cell carcinoma (PSCC)
Beyond the preview
Go deeper on 2012-002592-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002592-34.